» Articles » PMID: 32235493

Nuclear Magnetic Resonance Metabolomics Biomarkers for Identifying High Risk Patients with Extranodal Extension in Oral Squamous Cell Carcinoma

Overview
Journal J Clin Med
Specialty General Medicine
Date 2020 Apr 3
PMID 32235493
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

Extranodal extension (ENE) is an independent adverse prognostic factor in oral squamous cell carcinoma (OSCC), and is difficult to identify preoperatively. We aimed to discover biomarkers for high risk patients with ENE. Tandem tissue, plasma, and urine samples of 110 patients with OSCC were investigated through 600-MHz nuclear magnetic resonance (NMR) metabolomics analysis. We found that the levels of creatine, creatine phosphate, glycine, and tyramine in plasma significantly decreased in stage IV ENE positive OSCC compared with stage IV ENE negative OSCC. To understand the underlying mechanism behind the alteration of plasma metabolites, our tissue analysis revealed that the carnitine level significantly increased in tumors but significantly decreased in the adjacent normal tissue in advanced stage OSCC, in addition to decreased levels of alanine and pyruvate in tumor tissues. The global metabolomics analysis on tumor tissues also showed that stage IV tumors with an ENE positive status demonstrated higher levels of aspartate, butyrate, carnitine, glutamate, glutathione, glycine, glycolate, guanosine, and sucrose but lower levels of alanine, choline, glucose, isoleucine, lactate, leucine, myo-inositol, O-acetylcholine, oxypurinol, phenylalanine, pyruvate, succinate, tyrosine, valine, and xanthine than tumors with an ENE negative status. We concluded that metabolomics alterations in tumor tissues correspond to an increase in the tumor stage and are detectable in plasma samples. Metabolomic alterations of OSCC can serve as potential diagnostic markers and predictors of ENE in patients with stage IV OSCC.

Citing Articles

Intratumoral Microbiome: Foe or Friend in Reshaping the Tumor Microenvironment Landscape?.

Kyriazi A, Karaglani M, Agelaki S, Baritaki S Cells. 2024; 13(15.

PMID: 39120310 PMC: 11312414. DOI: 10.3390/cells13151279.


Targeting histone deacetylases in head and neck squamous cell carcinoma: molecular mechanisms and therapeutic targets.

Xu M, Hou Y, Li N, Yu W, Chen L J Transl Med. 2024; 22(1):418.

PMID: 38702756 PMC: 11067317. DOI: 10.1186/s12967-024-05169-9.


Biological biomarkers of oral cancer.

Radaic A, Kamarajan P, Cho A, Wang S, Hung G, Najarzadegan F Periodontol 2000. 2023; 96(1):250-280.

PMID: 38073011 PMC: 11163022. DOI: 10.1111/prd.12542.


Aldolase B-driven lactagenesis and CEACAM6 activation promote cell renewal and chemoresistance in colorectal cancer through the Warburg effect.

Chu Y, Cheng L, Lim S, Lai M, Yeh C, Lin W Cell Death Dis. 2023; 14(10):660.

PMID: 37816733 PMC: 10564793. DOI: 10.1038/s41419-023-06187-z.


Evaluation of Metabolomics as Diagnostic Targets in Oral Squamous Cell Carcinoma: A Systematic Review.

Alapati S, Fortuna G, Ramage G, Delaney C Metabolites. 2023; 13(8).

PMID: 37623834 PMC: 10456490. DOI: 10.3390/metabo13080890.


References
1.
Taghavi N, Yazdi I . Prognostic factors of survival rate in oral squamous cell carcinoma: clinical, histologic, genetic and molecular concepts. Arch Iran Med. 2015; 18(5):314-9. DOI: 0151805/AIM.0010. View

2.
Lydiatt W, Patel S, OSullivan B, Brandwein M, Ridge J, Migliacci J . Head and Neck cancers-major changes in the American Joint Committee on cancer eighth edition cancer staging manual. CA Cancer J Clin. 2017; 67(2):122-137. DOI: 10.3322/caac.21389. View

3.
Hsieh Y, Chen Y, Lin S, Chang K, Li W . Targeting Cellular Metabolism Modulates Head and Neck Oncogenesis. Int J Mol Sci. 2019; 20(16). PMC: 6721038. DOI: 10.3390/ijms20163960. View

4.
Evans M, Baddour Jr H, Magliocca K, Muller S, Nannapaneni S, Chen A . Prognostic implications of peritumoral vasculature in head and neck cancer. Cancer Med. 2018; 8(1):147-154. PMC: 6346230. DOI: 10.1002/cam4.1910. View

5.
Bag S, Banerjee D, Basak A, Das A, Pal M, Banerjee R . NMR ((1)H and (13)C) based signatures of abnormal choline metabolism in oral squamous cell carcinoma with no prominent Warburg effect. Biochem Biophys Res Commun. 2015; 459(4):574-8. DOI: 10.1016/j.bbrc.2015.02.149. View